Table 4 Occurrence of lumbopelvic pain and the respective pain scores of the intervention and control group
Prevalence of pain | BPP group N (%) | Control group N (%) | RR (95%CI) | n |
|---|---|---|---|---|
Lumbar pain | ||||
Baseline | 57 (58.8) | 65 (65.0) | 0.90 (0.73–1.13) | 197 |
Intermediate evaluation | 53 (59.6) | 47 (63.5) | 0.94 (0.74–1.20) | 164 |
Final evaluation | 54 (63.5) | 48 (63.2) | 1.01 (0.79–1.27) | 161 |
Pelvic pain) | ||||
Baseline | 14 (14.4) | 15 (15.0) | 0.96 (0.49–1.89) | 197 |
Intermediate evaluation | 24 (27.0) | 15 (20.3) | 1.33 (0.75–1.34) | 164 |
Final evaluation | 24 (28.2) | 21 (27.6) | 1.02 (0.62–1.68) | 161 |
Intensity of pain | VAS (cm) | VAS (cm) | Mean difference (95% CI) | |
Lumbar pain (mean±sd) | ||||
Baseline | 4.7 ± 2.7 | 4.5 ± 2.2 | 0.23 (-0.64–1.09) | 122 |
Intermediate evaluation | 5.1 ± 2.3 | 5.1 ± 2.5 | 0.08 (-0.86–1.03) | 99 |
Final evaluation | 5.1 ± 2.3 | 4.8 ± 2.5 | 0.34 (-0.61–1.28) | 102 |
Pelvic pain (mean±sd) | ||||
Baseline | 3.8 ± 2.1 | 4.7 ± 2.4 | -0.9 (-2.49–0.78) | 29 |
Intermediate evaluation | 4.9 ± 2.7 | 5.4 ± 2.3 | -0.47 (-2.12–1.19) | 39 |
Final evaluation | 5.5 ± 2.9 | 5.9 ± 2.8 | -0.38 (-2.09–1.33) | 44 |